OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 37 filers reported holding OCULAR THERAPEUTIX INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $267,000 | 0.0% | 67,202 | 0.0% | 0.00% | – |
| Q4 2018 | $267,000 | -71.1% | 67,202 | -50.0% | 0.00% | -100.0% |
| Q3 2018 | $924,000 | +153.2% | 134,404 | +148.2% | 0.00% | – |
| Q2 2018 | $365,000 | +31.3% | 54,141 | +26.9% | 0.00% | – |
| Q1 2018 | $278,000 | +46.3% | 42,679 | 0.0% | 0.00% | – |
| Q4 2017 | $190,000 | -28.0% | 42,679 | 0.0% | 0.00% | – |
| Q3 2017 | $264,000 | -33.3% | 42,679 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $396,000 | +6.2% | 42,679 | +6.2% | 0.00% | 0.0% |
| Q1 2017 | $373,000 | +19.6% | 40,179 | +7.7% | 0.00% | – |
| Q4 2016 | $312,000 | +79.3% | 37,318 | +47.7% | 0.00% | – |
| Q3 2016 | $174,000 | +39.2% | 25,268 | 0.0% | 0.00% | – |
| Q2 2016 | $125,000 | -39.6% | 25,268 | +17.9% | 0.00% | – |
| Q1 2016 | $207,000 | +3.0% | 21,432 | 0.0% | 0.00% | – |
| Q4 2015 | $201,000 | -24.7% | 21,432 | +12.7% | 0.00% | -100.0% |
| Q3 2015 | $267,000 | -33.2% | 19,014 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $400,000 | +14.6% | 19,014 | +128.9% | 0.00% | 0.0% |
| Q1 2015 | $349,000 | +79.0% | 8,307 | 0.0% | 0.00% | – |
| Q4 2014 | $195,000 | +143.8% | 8,307 | +55.0% | 0.00% | – |
| Q3 2014 | $80,000 | – | 5,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |